- This event has passed.
From Resistance to Resilience
May 14, 2024 @ 5:30 pm - 8:30 pm
On the margins of the multistakeholder hearings on antimicrobial resistance, Foreign Policy and IFPMA are organizing an in-person, high-profile discussion on what it takes to reinforce the response to AMR and the collaborations, reforms and actions that would help drive significant progress in the space.
Antimicrobial resistance has emerged as a significant threat to global health, with the World Health Organization (WHO) classifying it among the top 10 public health threats. The urgency of the issue is underscored by alarming statistics: In 2019, AMR was responsible for 1.27 million deaths and contributed to nearly five million more. It’s a crisis that impacts every aspect of medicine, from routine dental procedures to complex surgeries and cancer treatments. Predictions indicate that by 2050, AMR could cause 10 million deaths annually, surpassing many current leading causes of death.
As the risks from AMR and bacteria that are resistant to currently available antibiotics mount, greater awareness and coordinated action are needed to understand the scale and scope of the threats and streamline investments and interventions that can have impact at scale.
The event will feature new data from IFPMA that sheds light on the state of the antibiotic pipeline and future outlook, and it will serve as an important prelude to the multistakeholder hearings on AMR in May and the high-level meeting that will be held at the UN General Assembly in September.
Topics and speakers include:
Status Check: The Ongoing Battle Against AMR
Ambassador Alicia Buenrostro Massieu, Alternate Permanent Representative, Permanent Mission of Mexico to the United Nations
A Frontline Perspective on AMR
Amanda Jezek, Senior Vice President, Public Policy and Government Relations, Infectious Diseases Society of America (IDSA)
What could the future antibiotic pipeline look like?
James Anderson, Executive Director, Global Health, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Innovation & Action: Private Sector’s Role
Damiano de Felice, Chief of External Affairs, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Dr. Akhila Kosaraju, CEO & President, Phare Bio
Dr. Jenelle Krishnamoorthy, Vice President and Head of Global Public Policy, Merck
Ramanan Laxminarayan, Founder & President, One Health Trust
Next Steps: Putting AMR Governance into Practice
Niall Fry, Foreign, Commonwealth & Development Office (FCDO), United Kingdom
Dr. Malin Grape, Swedish Ambassador on Antimicrobial Resistance, Ministry of Health and Social Affairs, Sweden
Stewart Simonson, World Health Organization Representative, United Nations